AU3289700A - Tetrahydropyridazine derivatives - Google Patents

Tetrahydropyridazine derivatives

Info

Publication number: AU3289700A
Authority: AU; Australia
Prior art keywords: tetrahydropyridazine derivatives; tetrahydropyridazine; derivatives
Prior art date: 1999-04-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

AU32897/00A

Other languages

English (en)

Inventor

Norbert Dr. Beier

Claus Fittschen

Franz-Werner Kluxen

Jonas Rochus

Michael Dr. Wolf

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Patent GmbH

Original Assignee

Merck Patent GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-06

Filing date

2000-03-15

Publication date

2000-10-23

2000-03-15 Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH

2000-10-23 Publication of AU3289700A publication Critical patent/AU3289700A/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU32897/00A 1999-04-06 2000-03-15 Tetrahydropyridazine derivatives Withdrawn AU3289700A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19915365A DE19915365A1 (de)	1999-04-06	1999-04-06	Tetrahydropyridazin-Derivate
DE19915365		1999-04-06
PCT/EP2000/002275 WO2000059890A1 (de)	1999-04-06	2000-03-15	Tetrahydropyridazin-derivate

Publications (1)

Publication Number	Publication Date
AU3289700A true AU3289700A (en)	2000-10-23

Family

ID=7903584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU32897/00A Withdrawn AU3289700A (en)	1999-04-06	2000-03-15	Tetrahydropyridazine derivatives

Country Status (4)

Country	Link
AR (1)	AR023262A1 (de)
AU (1)	AU3289700A (de)
DE (1)	DE19915365A1 (de)
WO (1)	WO2000059890A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19915364A1 (de) *	1999-04-06	2000-10-12	Merck Patent Gmbh	Verwendung von Arylalkanoylpyridazinen
EP1368035A1 (de) *	2001-02-12	2003-12-10	MERCK PATENT GmbH	Verwendung von typ 4 phosphodiesteraseinhibitoren bei myokarderkrankungen
HUP0401984A3 (en) *	2001-10-31	2005-06-28	Merck Patent Gmbh	Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
CA2620333A1 (en)	2005-08-26	2007-03-01	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP2258359A3 (de)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
AU2006304787A1 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by PDE inhibition
EP2314289A1 (de)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba-rezeptor-vermittelte modulation von neurogenese
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
EP2021000A2 (de)	2006-05-09	2009-02-11	Braincells, Inc.	Neurogenese mittels angiotensin-modulation
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
US20100216805A1 (en)	2009-02-25	2010-08-26	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19632549A1 (de) *	1996-08-13	1998-02-19	Merck Patent Gmbh	Arylalkanoylpyridazine

1999
- 1999-04-06 DE DE19915365A patent/DE19915365A1/de not_active Withdrawn
2000
- 2000-03-15 AU AU32897/00A patent/AU3289700A/en not_active Withdrawn
- 2000-03-15 WO PCT/EP2000/002275 patent/WO2000059890A1/de not_active Ceased
- 2000-04-05 AR ARP000101548A patent/AR023262A1/es unknown

Also Published As

Publication number	Publication date
DE19915365A1 (de)	2000-10-12
WO2000059890A1 (de)	2000-10-12
AR023262A1 (es)	2002-09-04

Publication	Publication Date	Title
AU6314900A (en)	2001-02-13	Biarylurea derivatives
AU6714700A (en)	2001-03-26	Cyclopropylindole derivatives
AU1173201A (en)	2001-05-14	Skin-gripper
AU2001271434A1 (en)	2003-01-08	Novel skateboard-bicycle combination
AU2678800A (en)	2000-09-04	Modified calycins
AU5429000A (en)	2001-01-31	Novel bicyclonucleoside derivatives
AU7319800A (en)	2001-04-24	4-oxybenzopyran derivative
AU5967600A (en)	2001-02-13	Candystraw
AU3670000A (en)	2000-10-23	Novel thiazolobenzimidazole derivatives
AU7952800A (en)	2001-04-30	2-alkoxybenzene derivatives
AU4115400A (en)	2000-11-14	Short-circuiter
AU3289700A (en)	2000-10-23	Tetrahydropyridazine derivatives
AU7453900A (en)	2001-05-10	4-oxybenzopyran derivative
AU6335000A (en)	2001-04-24	Depthimeter
AU2699800A (en)	2000-09-04	Organoceramics
AU2023701A (en)	2001-06-18	Sketcher
AU6262300A (en)	2001-01-02	Indolinylamide derivatives
AU6098300A (en)	2001-02-05	Follistatin-3
AU4916900A (en)	2000-12-05	Benzofuranylsulfonates
AU1558300A (en)	2001-03-05	1-cycloalkylpyrazoyl-benzoyl derivatives
AU1901801A (en)	2001-05-30	Glucofuranoses
AU5666800A (en)	2001-01-09	Difuropyrone derivatives
AU2028401A (en)	2001-06-18	3-methyl-chromane or thiochromane derivatives
AU4435300A (en)	2000-11-10	Hula-hoop
AU7303400A (en)	2001-04-24	Osseo-distractor

Legal Events

Date	Code	Title	Description
2001-09-06	MK13	Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant